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MYRbase: analysis of genome-wide glycine myristoylation enlarges the functional spectrum of eukaryotic myristoylated proteins We evaluated the evolutionary conservation of glycine myristoylation within eukaryotic sequences. Our large-scale cross-genome analyses,  available as MYRbase, show that the functional spectrum of myristoylated proteins is currently largely underestimated. We give experimen- tal evidence for in vitro myristoylation of selected predictions. Furthermore, we classify five membrane-attachment factors that occur most  frequently in combination with, or even replacing, myristoyl anchors, as some protein family examples show.
Abstract
We evaluated the evolutionary conservation of glycine myristoylation within eukaryotic sequences.
Our large-scale cross-genome analyses, available as MYRbase, show that the functional spectrum
of myristoylated proteins is currently largely underestimated. We give experimental evidence for
in vitro myristoylation of selected predictions. Furthermore, we classify five membrane-attachment
factors that occur most frequently in combination with, or even replacing, myristoyl anchors, as
some protein family examples show.
Background
Myristoylation is an important lipid modification of a variety
of eukaryotic and viral, and also a few bacterial, proteins [1-4]
that can direct proteins to membranes. There, it can influence
their submembrane localization (for example, in lipid raft or
raft-like compartments [5]) as a function of additional factors
(for example, subsequent palmitoylation or the possession of
a polybasic region) [6,7]. Also, myristoyl anchors have been
found to be involved in specific protein-protein interactions
[8,9]. Complex conformational switches can trigger changes
in accessibility of the lipid moiety [10-13]. The enzyme myris-
toyl-CoA:protein N-myristoyltransferase (NMT) [14] recog-
nizes a motif [15] at the amino terminus of substrate proteins
(which can also become amino-terminal after proteolytic
cleavage) and attaches myristic acid, a saturated 14-carbon
fatty acid, to the amino-terminal glycine. As bacteria and
viruses, with the exception of two predicted NMTs in
entomopoxviruses [15], lack the myristoylating enzyme, their
proteins are modified by eukaryotic host NMT.
A sensitive prediction method using position-specific, redun-
dancy-corrected profiles of known substrates in combination
with physicochemical constraints on enzyme-substrate inter-
actions has been developed [16] and is available from the web
[17]. The sensitivity (cross-validation performance over the
learning set of known substrates) is above 95% and the rate of
false-positive prediction is estimated as <0.5% for the general
eukaryotic, and <0.3% for the fungal, parameter set for pro-
teins starting with glycine. The authors acknowledge that
taxon-dependent enzyme-substrate specificities might influ-
ence prediction performances to a larger extent than included
in the current implementation of the prediction algorithm.
Large-scale application of this NMT predictor over GenBank
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(NCBI)) produces lists of thousands of potential NMT
substrates. The total number of analyzed sequences and
expected number of true predictions after subtraction of
potential false positives are given in Table 1.
To make these data more accessible and interpretable in
terms of biological significance, we evaluated the evolution-
ary conservation of the predicted myristoylation motif among
groups of homologous proteins. This approach ranks pre-
dicted myristoylated proteins according to the number of
homologous sequences with a conserved motif for this com-
mon lipid modification. Although not an absolute require-
ment, the evolutionary conservation of a motif in large
protein families can be used to postulate its functional impor-
tance. These results are accessible through MYRbase [18], an
easily navigable, searchable, web-based collection of tables
containing the multiply linked and annotated results of our
large-scale predictions, ordered by their number of occur-
rences in clusters of closely related proteins.
A more detailed description of MYRbase is given in the next
section and on the accompanying website [18]. The main part
of this manuscript is dedicated to a comprehensive discussion
of the results, which also include the in vitro experimental
verification of predicted myristoylation for amino-terminal
peptides derived from human homologs of several non-obvi-
ous substrates (for example, 47 kDa GTPase IIGP, ubiquitin
hydrolase Ubq-M, lung cancer candidate FUS1, potassium
channel Kir2.1 and potassium channel interacting protein
KChIP1). From these results we suggest extending the previ-
ously known functional spectrum of myristoylated proteins,
representing a first step towards a characterization of the
entire set of myristoylated proteins.
MYRbase
We applied the NMT predictor for glycine myristoylation to
taxonomic subsets of publicly available databases (SWISS-
PROT, GenBank). The NMT prediction methodology is
described in detail elsewhere [16]. Then, we first removed
redundancy within our predictions using the program mcd-
hit [19,20] with a 40% amino-acid identity threshold. This
procedure already results in a dramatic reduction of the pre-
diction lists to a much smaller set of representative sequences
(for example, from approximately 4,400 sequences to
approximately 2,000 for the eukaryotic subset). So as not to
lose the information in the removed sequences, they were
assigned to groups according to their clustering by mcd-hit.
The conservative threshold of 40% amino-acid identity allows
the interpretation that sequences within the clusters are
homologous to their representative sequence but also results
in the appearance of more remotely related sequences in sep-
arate clusters. The size of these clusters was used to rank the
representative sequences in the tables in the database and is
linked to view the full set of sub-tables listing all cluster
members.
We have also estimated the taxonomic distribution of
sequences within a cluster, as occurrence in a larger set of
organisms might reflect the functional need for conservation
of the motif during the aeons of evolution. Special emphasis
is given to the known experimental status of myristoylation to
distinguish new predictions. Therefore, we indicate the anno-
tation of a cluster member for myristoylation in the SWISS-
PROT [21] database below the cluster size and add further
details to the sequence description. Besides this short
description of the protein, the predictions are linked to their
corresponding GenBank entries, an RPS-Blast with CD-
search [22] to view the domain architecture and PSI-Blast
[23] to collect the set of homologous sequences.
Then, the position in the sequence of the glycine that is pre-
dicted to be myristoylated (position 2 often implies prior
cleavage of a leading methionine) and the full-length motif
follow. We highlight cysteines that could be subject to palmi-
toylation in yellow and positive charges by a blue background.
Both factors can not only influence membrane affinity but
also induce changes in subcompartment-specific localiza-
tions [5]. Finally, the score assigned by the NMT predictor
(yielding details of the single score components on mouse-
over), the estimated probability of false-positive prediction
and a simple prediction attribute are listed.
Entries in MYRbase can be accessed by simple browsing or
entering the corresponding MYRbase identifier on the index
page (MYRbase identifiers correspond to GenInfo numbers of
entries from the latest database built). Alternatively, we rec-
ommended using our MYRbase-specific BLAST-engine (also
Table 1
Numbers of analyzed sequences, experimentally verified myris-
toylated proteins plus their homologs and the set of additional 
new predictions
Number in 
GenBank*
Number 
experimentally 
verified + 
homologs†
Number 
established 
NEW true 
predictions‡
Total 600,916 1,122 2,037
Leading 
methionine§
426,128 997 1,548
*Eukarya, non-identical sequences (nr100), February 2003. 
†Experimentally verified myristoylated proteins and their homologs 
with conserved myristoylation site (BLASTP E-value <0.005, plus 
manual curation). ‡Estimated NEW true predictions: (total number of 
predictions) minus (expected number of false-positive predictions) 
minus (number of experimentally verified + homologs) = number of 
true predictions not closely related to already experimentally verified 
examples (possibly additional new functions for myristoylated 
proteins?). §When a leading methionine is present in the sequence, it is 
less likely to represent a non-amino-terminal fragment in the database. 
However, this also excludes some true amino-terminal fragments, 
where a glycine becomes amino-terminal after proteolytic cleavage.http://genomebiology.com/2004/5/3/R21 Genome Biology 2004,     Volume 5, Issue 3, Article R21       Maurer-Stroh et al. R21.3
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Genome Biology 2004, 5:R21
available from the index page) to be linked directly to the clus-
ter of the best hit of the query protein with MYRbase entries.
Results and discussion
Conservation of glycine myristoylation in the evolution 
of eukaryotes
When analyzing single eukaryotic genomes of human, mouse,
fly, worm, yeast and plant, we found a conserved relative
occurrence (around 0.5-0.8% of all proteins in the genome) of
predicted myristoylated proteins, with an elevated percent-
age for Arabidopsis [16] that is also supported by combined
theoretical/experimental data for this organism [24]. In our
genome-spanning analysis, we find that the most prominent
and taxonomically widespread groups of myristoylated pro-
teins comprise GTP-binding proteins (several alpha subunits
of G proteins and ADP ribosylation factors), serine/threonine
kinases, calcium-binding EF-hand proteins with diverse
functions (for example, recoverin, calcineurin B, guanylate
cyclase activators) and tyrosine kinases (see Table 2 for com-
plete listing).
It is interesting that for proteins with conserved myristoyla-
tion there are a few families with a large number of members,
and a large number of families with only a few members. An
interpretation of this situation, which is reminiscent of a
power-law distribution (see Figure 1 and legend), in evolu-
tionary terms might be that the few larger families are the old-
est cases of eukaryotic protein glycine myristoylation. The
many smaller families, on the other hand, appear to be exam-
ples of functional specialization, as they are often confined to
taxonomic subgroups. Most of the larger families with a con-
served motif include proteins with experimentally verified
myristoylation (Table 2). Hence, future research will focus on
the role of the predicted lipid anchors for the specialized
smaller groups.
The amino-terminal myristoylation motif is an 
exchangeable module in evolution
We do not only observe myristoylation of proteins specific to
taxonomic subgroups but also examples of myristoylation of
proteins from some species that have multiple orthologs in
other species that lack the motif for this lipid modification. In
several of these cases, the myristoyl anchor has been substi-
tuted by other factors that can facilitate membrane associa-
tion, such as other lipid anchors (palmitoyl, farnesyl,
geranylgeranyl), transmembrane regions or specific protein-
lipid or protein-membrane protein interaction domains. Such
substitutions can have occurred not only in orthologs and
paralogs but even in isoforms of the same protein.
For example, several Gα subunits have either a myristoyl-,
both myristoyl- and palmitoyl-, or only palmitoyl-anchors
[25]. While the Arabidopsis  Rab5 ortholog Ara7 is geran-
ylgeranylated on carboxy-terminal cysteines just like Rab5 in
other species, its closely related paralog Ara6 lacks the car-
boxy-terminal cysteines but has an experimentally verified
amino-terminal myristoylation motif instead [26]. Further-
more, it has been shown that an artificially introduced trans-
membrane helix can substitute for acyl-mediated membrane
targeting of eNOS [27]. While most phospholipase C-
gamma's are expected to be targeted to membranes by amino-
terminal pleckstrin homology domains (PH, which bind
phospholipids), a phospholipase C in Trypanosoma cruzi uti-
lizes a myristoyl-anchor instead [28]. Indeed, myristoylation
was also able to substitute for PH domain-mediated mem-
brane targeting of the scaffolding protein Gab1 [29].
Diverse shuffling, similar to that of globular domains, of sev-
eral membrane-attachment factors (MAFs) within homolo-
gous proteins apparently occurred during evolution (by
substitution, addition or deletion). It should be noted, how-
ever, that most of these changes also imply drift in targeting
specificity or strength, and that the contributions and impor-
tance of single MAFs for membrane attachment might differ.
The notion of evolutionary modularity should not be misun-
derstood as a common ancestry for all sequence segments
comprising myristoylation motifs. On the contrary, sequence-
based comparisons appear to favor a model of multiple inde-
pendent evolution (for example, for the emergence of those
single motifs; data not shown). The modularity we describe
here is that targeting specificity is achieved by combining dif-
ferent modules for membrane attachment in arrangements
that are not fixed but can change dynamically during evolu-
tion. The evolutionary steps required for these changes from
one targeting motif to the other are most likely to involve
intermediates that contain several of the interchangeable
factors.
Myristoyl anchors mediate targeting of proteins to 
many locations inside and outside of cells
Such evolution has apparently led to lipid-anchor-mediated
targeting to a wide range of subcellular localizations. The role
of glycine myristoylation is not limited to the classical attach-
ment of proteins to the plasma membrane. There, several
myristoylated proteins are found to target cholesterol and
sphingolipid-enriched detergent-resistant compartments,
designated as lipid rafts [30]. In addition, the myristoyl
anchor is involved in targeting proteins to membranes
throughout the cell, ranging from endoplasmic reticulum
(ER), Golgi and mitochondrial membranes to the nuclear
envelope and even to extracellular localization (see Table 2).
Extracellular localization is the result of an alternative myris-
toylation- and palmitoylation-dependent export mechanism
identified in Leishmania and possibly conserved to higher
eukaryotes [31].
Specificity and strength of targeting can be achieved by opti-
mizing lipid interactions by the type and number of lipid
anchors (for example, acyl (myristoyl, palmitoyl) [6], prenyl
(farnesyl, geranylgeranyl) [32,33] and GPI [34,35]), possiblyR21.4 Genome Biology 2004,     Volume 5, Issue 3, Article R21       Maurer-Stroh et al. http://genomebiology.com/2004/5/3/R21
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Table 2
Experimentally verified myristoylated proteins and their subcellular localizations
Experimentally verified protein type(s) Total number in MYRbase Subcellular localization References
GTP-binding proteins 288
G-protein alpha subunits (Gαi), Gαz), Gαo), Gαt)) 201 Type-dependent (receptor-specificity); for example, 
cytosol/plasma membrane (lipid rafts)
[25,95]
ADP ribosylation factors (ARF) and ARF-like 
(ARL)
79 Type-dependent; cytosol, intracellular membranes, 
cytoskeleton, nucleus/nucleolus (for example, ARL4, 
ARL5)
[109,110]
Rab5-related (Ara6)8Cytosol, endosomes, ER, plasma membrane[26]
S/T-kinases206
Ca2+/calmodulin-dependent kinases82Type-dependent; for example, cytosol, plasma 
membrane, ER membrane
[111]
Fen, Pto and related S/T-kinases 60 Cytosol, plasma membrane (~) [112]
cAMP-dependent kinases (PKA catalytic subunit) 51 (Nucleus)/cytosol/(plasma membrane over 
anchoring proteins)
[113,114]
cGMP-dependent kinase II 13 (Cytosol)/plasma membrane [115]
Ca2+-binding EF-hand proteins 141
Recoverin, neuronal calcium sensor, visinin, 
frequenin, neurocalcin, hippocalcin,
66 Type-dependent, triggered by Ca2+/myristoyl switch; 
for example, cytosol, plasma membrane, Golgi, 
neurofilament-rich structures
[78,116]
Calcineurin B phosphatase subunit, p22 43 Cytosol, plasma membrane (phosphatidylserine-rich 
regions), microtubule cytoskeleton (p22)
[117,118]
Guanylate cyclase activators 21 Cytosol/rod outer segment membranes of 
photoreceptor cells
[119]
DNA-dependent kinase interacting protein KIP = 
calcium and integrin binding protein CIB = 
calmyrin
11 Cytosol, plasma membrane, ER, nuclear envelope, 
nucleoplasm, cytoskeleton
[120,121]
Other
Tyrosine kinases (Abl, Blk, Fgr, Fyn, Hck, Lck, Lyn, 
Src, Yes)
136 Type-dependent; for example, cytosol/plasma 
membrane (lipid rafts/caveolae)
[122,123]
t-Actin (15 kDa carboxy-terminal fragment of 
cytoskeletal actin after caspase cleavage)
89* Cytosol, mitochondrial membrane [16,124]
26S ATP/ubiquitin-dependent protease regulatory 
subunit 4
26 Nucleus, cytosol, microsomes [16,62,125]
Endothelial nitric oxide synthase (eNOS) 18 Cytosol, Golgi, plasma membrane (lipid rafts/
caveolae)
[126,127]
Golgi reassembly stacking protein 1 (65 kDa) and 
2 (55 kDa)
17 Golgi membrane [128,129]
Myristoylated alanine-rich carboxy-kinase 
substrate (MARCKS)
15 Cytosol, cytoskeleton, plasma membrane (lipid rafts) [101]
Flagellar calcium-binding proteins in 
trypanosomes
14 Flagellar membrane [130]
NADH cytochrome b-5 reductase (diaphorase) 14 Cytosol, ER membrane, mitochondrial outer 
membrane
[131]
43 kDa acetylcholine receptor-associated protein 
of the synapse (RAPSYN)
13 Cytosol, Golgi, plasma membrane (lipid rafts/
caveolae)
[99]
S/T protein phosphatase + EF hand (PPEF) 12
Axons, dendrites, ciliar membranes
[132]
Hydrophilic acylated surface protein B (HASPB) 10 Extracellular (!) face of the plasma membrane [31]
Erythrocyte membrane protein band 4.2 (Pallidin) 10 Plasma membrane, intracellular vesicles [133]http://genomebiology.com/2004/5/3/R21 Genome Biology 2004,     Volume 5, Issue 3, Article R21       Maurer-Stroh et al. R21.5
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aided by additional features (such as clusters of positive
charges [36]), but also by specific protein-lipid (for example,
PIP2 [37]) and protein-protein (for example, PDZ domain
[38]) interactions.
Classification of five membrane-attachment factors 
frequently co-occurring with myristoyl anchors 
(coMAFs)
As several factors in addition to myristoylation contribute to
subcellular localization and membrane attachment, we have
analyzed their distribution within our sets of known and pre-
dicted myristoylated proteins. We distinguish five major
classes that are defined in Table 3 and depicted in Figure 2.
From our analysis, subsequent cysteine palmitoylation (class
I) and clusters of positive charges (class II) seem to occur in
comparable amounts in both known and predicted subsets,
while there is a clear tendency for the remaining classes (class
III-V) to be more common among the new predictions. The
prediction of the myristoylation of eukaryotic transmem-
brane proteins (class IV), in particular, will have to be verified
in the future, although it seems generally reasonable, as viral
examples exist [39,40] and the very similar acyl modification
with palmitoyl anchors is commonly found in combination
with transmembrane regions [41].
We also expect that final targeting specificity will be deter-
mined by not one but a combination of several MAFs, and the
subcellular localization will remain difficult to predict, espe-
cially in regard to the involvement of protein-protein interac-
tions (class V). Reversibility of membrane attachment can be
Vps15 (phosphatidylinositol 3-kinase-associated 
p150)
10 Cytosol, intracellular membranes (late Golgi) [134]
Neuronal axonal membrane protein NAP-22 
(brain acid soluble protein 1 BASP1; CAP23)
9 Golgi, plasma membrane (lipid rafts) [97]
SSeCKS (A-kinase anchor protein 12) 9 Cytosol, cytoskeleton, plasma membrane [135]
Sip2, beta subunits of 5'-AMP-activated protein 
kinase
9 Cytosol, plasma membrane [136]
T-lymphoma invasion and metastasis inducing 
protein 1 (TIAM1 protein)
9 Cytosol, plasma membrane [137]
PSD-Zip70, FEZ1 9 Neuronal membranes (postsynaptic density, 
dendritic rafts), plasma membrane (lipid rafts)
[138]
S/T protein phosphatase Z 8 Nucleus [139]
Annexin XIII 6 Cytosol, Golgi, plasma membrane (apical, lipid rafts) [100]
Ezrin-binding partner PACE-1 6 Cytosol, Golgi, lamellipodia [140]
BH3 interacting domain death agonist (BID) 5 Cytosol, mitochondrial membrane [45]
Calpastatin (testis-specific isoform tCAST) 5 Cytosol, intracellular membranes [141]
A-kinase anchor protein 200 5 Cytosol, plasma membrane [142]
Golgi-associated PR-1 protein 5 Golgi, plasma membrane (lipid rafts/caveolae) [143]
Vps20 (vacuolar protein sorting) 4 Cytosol, endosomal membranes [144]
Adenylate kinase 1 4 Cytosol, plasma membrane [145]
A-kinase anchor protein 7 (18) 3 Cytosol, plasma membrane [114]
2'-5'-oligoadenylate synthetase splice form 2 3 Cytosol, rough ER, ribosomes, nucleus [57]
NADH ubiquinone dehydrogenase B18 3 Mitochondrial membrane [146]
Hisactophilin 1 and 2 (Histidine-rich actin binding 
protein)
2 Cytosol, plasma membrane, nucleus [147]
Phosphoinositide-specific phospholipase C in T. 
cruzi
2 Cytosol, plasma membrane [28]
Actin-myosin network maintenance protein Nullo 2 Plasma membrane (metaphase furrows during 
mitosis, cellularization front)
[148]
t-Gelsolin (fragment after caspase cleavage) 2* Not determined for myristoylated form, 
cytoskeleton(?)
[124]
Igloo (growth associated protein) 1 Cytosol, neuronal membranes [149]
Flagellar creatine kinase (ATP:guanido 
phosphotransferase)
1 Sperm tail membranes [150]
*Not yet in MYRbase; cleavage motif is not automatically detected but is predicted when submitted as fragment to the predictor.
Table 2 (Continued)
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regulated by depalmitoylation, disruption of the cluster of
positive charges through introduction of negative charges
(phosphorylation, deamidation of asparagine to aspartate), a
pH-dependent switch when there are histidines within the
positive charge clusters, or conformational changes due to
proteolytic cleavage, binding of small molecules or altered
protein-protein interactions.
The functional spectrum of myristoylated proteins is 
underestimated
From Table 2 we can see that the functional spectrum of
experimentally verified myristoylated proteins is much more
diverse than their well-known involvement in signaling.
However, complete analysis of eukaryotic sequences in Gen-
Bank suggests that, after subtraction of known examples and
their homologs, a significant number of proteins remain
whose function has not been implicated with myristoylation
so far (Table 1). To investigate the spectrum of these predic-
tions with functions 'new' to myristoylated proteins, we have
systematically analyzed the domain composition of a nonre-
dundant (90% identity) subset of the respective proteins
(HMMer [42] against PFAM [43]; E-value 0.01) and summa-
rize the results in Table 4 (ranked by the number of occur-
rences of domains and corrected for repeated occurrence of
the same domain in one entry). As a rule, the proteins associ-
ated with domain hits in Table 4 do not belong to a unique
protein family but to several families that differ in their over-
all domain architecture. Consequently, we also analyzed the
set of new predictions in respect of clearly defined protein
families, and summarize them in Table 5. This list only
includes families with at least 10 different proteins that, fur-
thermore, begin with a methionine in their sequence (for
exclusion of possible non-amino-terminal fragments). Not
surprisingly, as myristoylation of remotely related family
members has already been established, we find additional
examples of kinases, phosphatases and phosphodiesterases.
Several 'new' predictions will be discussed in the following
sections. If not listed in Tables 5 or 6, a MYRbase identifier
(MI) that equals the GenInfo number of the predicted entry in
the analyzed database will be given to access the correspond-
ing entries in MYRbase.
In vitro verification of selected predictions
We also picked a few interesting predictions from MYRbase
and investigated the capacity of the corresponding amino-ter-
minal peptides (Table 6 and Additional data file 1) to be myr-
istoylated. Our in vitro experiments with synthetic peptides
and bacterially expressed NMT (see Materials and methods)
confirm the computational results for specific immunoglobu-
lin µ-heavy and λ-light chains, 47 kDa GTPase IIGP, ubiquitin
hydrolase Ubq-M, lung cancer candidate FUS1, potassium
channel Kir2.1 and potassium channel interacting protein
KChIP1. Hence, we show that our predictor recognizes the
capability of substrates to productively interact with NMT.
However, it is clear that in vitro myristoylation of synthetic
peptides only gives limited information about the situation of
the full-length protein in vivo. Some positively predicted sub-
strates might be myristoylatable in vitro, but whether they
come into contact with NMT in vivo depends on the cellular
context and needs to be proven or at least shown to be
plausible.
Immunoglobulins and possible non-amino-terminal 
fragments in MYRbase
For example, MYRbase also includes a series of specific
immunoglobulin chains. By our in vitro myristoylation exper-
iments, we show for a µ-heavy and a λ-light chain (Table 6,
and Additional data file 1) that peptides derived from the
amino termini of the corresponding database entries are in
principal agreement with the physicochemical requirements
for productive substrate-NMT interaction as modeled by our
predictor.
It is unclear whether the predicted entries only represent
non-amino-terminal fragments in the database. Differing
sequence constructs for that region could be attributable to
V(D)J recombination [44]. However, we could not find
convincing expressed sequence tag (EST) evidence for vari-
ants with a starting methionine just before the predicted gly-
cines. Proteolytic cleavage is an alternative possibility for
glycines to become amino-terminal (for example, BID [45]
and several viral proteins). Immunoglobulin chains are nor-
mally targeted to the ER via signal peptides and the existence
of NMT activity in the ER has been proposed [2]. None of the
predicted cleavage sites [46] of immunoglobulin precursors
after the removal of the signal peptide appeared to result in an
amino-terminal glycine. However, a different subcellular tar-
geting mechanism, as well as alternative cleavage sites [47]
Power-law distribution of family clusters in MYRbase with maximal 40%  sequence identity and a minimal size of 3 (to exclude false positives) Figure 1
Power-law distribution of family clusters in MYRbase with maximal 40% 
sequence identity and a minimal size of 3 (to exclude false positives). The 
inset table gives the values and correlation coefficients for different 
minimal cluster sizes. The power function distribution (without shift along 
the argument axis x), the Pareto distribution and the Zipf's law (if the rank 
is approximated by the argument x) have the common analytical form y = 
a · xb. Such distributions generally occur as the limit distribution of a 
multiplicative stochastic process with a lower boundary constraint (here, 
minimal cluster size). The common phenomenological form does not imply 
a unified mechanism for generating samples obeying these distribution 
functions. We suggest interpreting cluster size in terms of time for 
evolutionary divergence within the cluster (see text).
y = axb
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and cleavage by other proteases, cannot be excluded. Myris-
toylation at the predicted sites may occur in vivo only if the
sequences, starting with glycine as they appear in the data-
base, can interact with NMT within the cell.
Early work exists describing in vivo incorporation of radiola-
beled myristate into the same specific immunoglobulin
chains as those predicted [48]. In this light, the possible alter-
native of myristoylation of an internal lysine (a theoretical
suggestion of Pillai and Baltimore [48]) has to be addressed
experimentally. Reports of internal lysine myristoylation are
rare in the literature [49,50]. These potentially myristoylated
immunoglobulin chains should have a yet-unknown cellular
function (possibly, in a cell-type and cell-state-dependent
manner) [48,51] in which the lipid anchor influences subcel-
lular targeting.
Myristoylation and the innate immune response
Plant-specific disease-resistance proteins, with the nucleo-
tide binding motif NB-ARC and leucine-rich repeat domains
(for protein-protein interactions), are prominent in Table 5.
While this manuscript was in preparation, octapeptides
derived from the amino terminus of respective proteins were
shown to be myristoylatable by plant NMT [24]. Myristoyla-
tion of those proteins that are involved in the innate immune
response [52] fits well into the scheme that they act through
interaction with avirulence proteins that are injected into the
plant host cell through the type III secretion system of the
parasitic bacteria [53]. The lipid anchor may facilitate co-
localization since a series of type-III secreted bacterial pro-
teins are also myristoylated by host plant NMT [4].
In the immune response of mammals to intracellular patho-
gens, expression of families of 65 kDa and 47 kDa GTPases is
induced by interferon-gamma [54]. In this work, we show in
vitro myristoylation (Table 6 and Additional data file 1) of the
amino terminus of a human homolog of 47 kDa GTPase IIGP
[55]. This protein seems to be the only family member,
besides very close homologs, that has a myristoyl anchor.
Lipid modifications are quite common within the large super-
family of GTP-binding proteins, for example, Ras and Ras-
related as well as Rho and Rab small GTPases are most often
either farnesylated or geranylgeranylated [32]. Also, mem-
bers of the 65 kDa family of the interferon-inducible GTPases
[54] share the CaaX box motif that most likely directs their
geranylgeranylation. In the case of the 47 kDa GTPase IIGP, a
myristoyl-anchor could be involved in localizing the protein
to membranes of the ER and Golgi [55,56]. In the context of
myristoylation and mammalian innate immune responses, it
is noteworthy that interferon-inducible, double-stranded (ds)
RNA-activated 2'-5'-oligoadenylate synthetase isoform 2 is
also known to be myristoylated [57].
Myristoylation and ubiquitination
The amino terminus of the human ubiquitin-specific protease
Ubp-M is myristoylated by NMT in vitro (Table 6, and Addi-
tional data file 1). This enzyme is suspected to be involved in
the deubiquitination of histone 2A, cell-cycle regulation and
caspase-dependent apoptosis [58,59]. However, the observa-
tions were made with a protein amino-terminally tagged with
green fluorescent protein (GFP), which questions the func-
tional importance of a putative amino-terminal myristoyl
anchor. Interestingly, only a GFP-tagged mutated inactive
version was localized to the nucleus, while the GFP-tagged
protein lacking inactivating mutations was found in the cyto-
plasm [58]. This indicates that several factors influence its
localization, and it cannot be ruled out that a myristoylated
amino terminus would result in a different localization pat-
tern, possibly also targeting the 'active' wild-type protein to
its actual place of action.
Table 3
The five classes of co-occurring membrane attachment factors (coMAFs)
coMAF class* I II III IV V
Palmitoylatable 
cysteine†
Amino-terminal 
cluster of positive 
charges‡
PIP2-specific binding 
domain§
Transmembrane 
segments¶
Other/not attributable 
(for example, protein-
protein interactions)¥
Experimentally verified 
+ homolog
453 443/133/12 9 0 432
Additional NEW 
prediction
728 729/269/58 21 203 1,860
*Distribution of the five classes of coMAFs among the set of experimentally verified myristoylated proteins plus their homologs and the set of 
additional new predictions. Assignments are not necessarily unique, but can be combinations thereof. †At least one palmitoylatable cysteine within 
the first five residues (starting with the myristoylated glycine). ‡The content of positive charges (amino acids lysine (K), arginine (R) and histidine (H)) 
in the region of positions 6 to 35 is compared to the average composition in GenBank in the same region. The values correspond to hits occurring 
using threshold deviations of 1, 2 and 3σ from the GenBank average. §Significant HMMER-hit (below E-value of 0.01) with phosphatidylinositol-
bisphosphate (PIP2)-specific binding domains (PH, ENTH, FERM, PX or FYVE). ¶A very conservative method was used to detect putative 
transmembrane segments. Besides requiring the attribute 'trusted' by the sensitive method DAS-TMfilter [151], we only list the hits that have more 
than three predicted TM regions and that are additionally filtered for their overall polarity measured by the content of positive charges. ¥All other 
proteins that did not fulfill any of the above criteria.R21.8 Genome Biology 2004,     Volume 5, Issue 3, Article R21       Maurer-Stroh et al. http://genomebiology.com/2004/5/3/R21
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In addition to Ubq-M, we predict myristoylation for another
group of ubiquitin-specific proteases conserved in rat, fly,
worm and plants (for example, MI 27683149). These proteins
are substantially shorter, lack additional domains (such as an
amino-terminal zinc finger in Ubq-M), and most probably
belong to the ubiquitin carboxy-terminal hydrolase subfamily
[60]. Furthermore, we predict that the Caenorhabditis ele-
gans cytokinesis defect protein 3 [61] has a myristoyl anchor
followed by a calcium-binding EF-hand and an ubiquitin
hydrolase homology domain (MI 16950531).
It might be interesting to check whether the predicted lipid
modification for some of these ubiquitin-specific proteases
could result in subcellular targeting similar to that of a 26S
proteasome variant whose regulatory subunit 4 was predicted
[16], and subsequently shown to be, myristoylated in vivo
[62].
In this context, it is also interesting that we predict myris-
toylation for a group of proteins containing putative RING
zinc finger domains (Tables 4 and 5) that are commonly
found in ubiquitin ligases. Although RING finger domains do
exist in some proteins known to be myristoylated (for exam-
ple, rapsyn, see Table 2), most of the hits with this top-rank-
ing domain in Table 4 seem to have 'new' functions in the
context of myristoylated proteins. For example, a subgroup of
the RING finger proteins are isoforms of the Notch pathway
[63] protein neuralized [64], with a conserved myristoylation
motif in human, mouse, frog, fly and worm (for example, MI
15128197). Another example of a RING domain-containing
protein with conserved myristoylation motif in human,
mouse, fly and worm is mahogunin (MI 27229238), which is
involved in spongiform neurodegeneration [65]. Also, the
myristoylation motif of the RING-containing peripheral
nerve injury gene nin283 (for example, MI 14150005) is con-
served in human, mouse, fly and worm.
Furthermore, several F-box-containing proteins, parts of
which could act as receptors for ubiquitination targets, are
found within our set of proteins predicted to be myristoylated
(for example, MI 6912466 and MI 7299840).
Myristoylation of mitochondrial proteins
As well as proteins involved in apoptosis or the mitochondrial
respiratory chain that are known to be myristoylated (Table
2), we also predict amino-terminal myristoylation of a
homolog of TOM40, a protein thought to be a central compo-
nent of the mitochondrial import machinery [66], presuma-
bly acting as a pore-forming [67] sorting station [68].
Unexpectedly for a proposed all-beta integral membrane
Schematic representation of the membrane attachment of proteins with a myristoyl anchor (dark gray, space-filling atomic representation) in combination  with different co-occurring membrane-attachment factors (coMAFs) Figure 2
Schematic representation of the membrane attachment of proteins with a myristoyl anchor (dark gray, space-filling atomic representation) in combination 
with different co-occurring membrane-attachment factors (coMAFs). Class I, plus palmitoyl anchor (also dark gray, space-filling); class II, plus cluster of 
positive charges (dark blue, spacefill); class III, plus PIP2-specific binding domain (PIP2 in space-filling, alkyl tails in cyan); class IV, plus transmembrane 
segments; class V, plus a domain for specific protein-membrane protein interactions. White space-filling molecules in the model membrane represent 
cholesterol and symbolize targeting to specialized compartments. Two different states of the calcium/myristoyl-switch of recoverin are depicted in the 
lower left of the figure (calcium ions in red). Visualization is with SwissPdb-Viewer [108].
I II III IV Vhttp://genomebiology.com/2004/5/3/R21 Genome Biology 2004,     Volume 5, Issue 3, Article R21       Maurer-Stroh et al. R21.9
c
o
m
m
e
n
t
r
e
v
i
e
w
s
r
e
p
o
r
t
s
r
e
f
e
r
e
e
d
 
r
e
s
e
a
r
c
h
d
e
p
o
s
i
t
e
d
 
r
e
s
e
a
r
c
h
i
n
t
e
r
a
c
t
i
o
n
s
i
n
f
o
r
m
a
t
i
o
n
Genome Biology 2004, 5:R21
Table 4
Domain composition of the set of new predictions
Number of entries ID Description
57 PF00097 Zinc finger, C3HC4 type (RING finger)
43 PF00069 Protein kinase domain
35 PF00481 Protein phosphatase 2C
26 PF00023 Ankyrin repeat
21 PF00931 NB-ARC domain
20 PF00646 F-box domain
18 PF04782 Protein of unknown function (DUF632)
18 PF04783 Protein of unknown function (DUF630)
16 PF00036 EF hand
14 PF00135 Carboxylesterase
14 PF00487 Fatty acid desaturase
13 PF00651 BTB/POZ domain
13 PF05049 Interferon-inducible GTPase (IIGP)
13 PF00233 3'5'-cyclic nucleotide phosphodiesterase
12 PF00443 Ubiquitin carboxyl-terminal hydrolase
12 PF00085 Thioredoxin
11 PF00001 7 transmembrane receptor (rhodopsin family)
11 PF00047 Immunoglobulin domain
9 PF00622 SPRY domain
9 PF00628 PHD-finger
9 PF00096 Zinc finger, C2H2 type
8 PF01459 Eukaryotic porin
8 PF03011 Plasmodium falciparum erythrocyte membrane protein (PFEMP)
8 PF00400 WD domain, G-beta repeat
8 PF00595 PDZ domain (Also known as DHR or GLGF)
8 PF00560 Leucine rich repeat
7 PF00520 Ion transport protein
7 PF01135 Protein-L-isoaspartate(D-aspartate) O-methyltransferase (PCMT)
7 PF00514 Armadillo/beta-catenin-like repeat
7 PF00989 PAS domain
7 PF00134 Cyclin, amino-terminal domain
7 PF00169 PH domain
6 PF00300 Phosphoglycerate Phos Phosphoglycerate mutase family
6 PF01145 SPFH domain / Band 7 family
6 PF01582 TIR domain
6 PF02174 PTB domain (IRS-1 type)
6 PF00462 Glutaredoxin
6 PF03193 Protein of unknown function, DUF258
6 PF00515 TPR domain
6 PF00240 Ubiquitin family
6 PF01265 Cytochrome c/c1 heme lyase
6 PF00702 haloacid dehalogenase-like hydrolase
6 PF04641 Protein of unknown function, DUF602
6 PF00271 Helicase conserved carboxy-terminal domain
5 PF00070 Pyridine nucleotide-disulphide oxidoreductase
5 PF01417 ENTH domain
5 PF00270 DEAD/DEAH box helicase
5 PF02230 Phospholipase/CarboxylesteraseR21.10 Genome Biology 2004,     Volume 5, Issue 3, Article R21       Maurer-Stroh et al. http://genomebiology.com/2004/5/3/R21
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protein of the outer mitochondrial membrane [69],
sequences from human, mouse, rat, frog and fly reveal a con-
served predicted myristoylation site at the amino terminus
(Table 5).
Interestingly, the amino termini of cytochrome c-type heme
lyase (CCHL) homologs in worm, fly, zebrafish, frog, mouse
and human (for example, MI 7512486) also share a conserved
predicted myristoylation motif. It should be noted that, in the
human sequence, a proline at motif position 4 is rather unfa-
vorable in terms of flexibility of the substrate to adopt the
proper conformation in the NMT binding pocket. Fungal
homologs also have amino-terminal glycines. Although possi-
ble myristoylation cannot be excluded, three large aromatic
residues that are difficult to accommodate in the narrow NMT
substrate-binding pocket follow these conserved glycines,
which might also suggest a new, as yet unknown, role for the
amino-terminal glycine conservation. CCHL catalyzes the
conversion of apocytochrome c  to holocytochrome c  by
attaching a heme group [70], which is an important step
required for cytochrome c biogenesis and transport through
the membranes [71]. Deletion of the mammalian gene encod-
ing CCHL is associated with X-linked microphthalmia with
linear skin defects syndrome [72].
Myristoylation of lung cancer candidate FUS1
We also show in vitro myristoylation of the amino terminus
of human FUS1 (Table 6 and Additional data file 1), an appar-
ent tumor suppressor. This protein is missing or carboxy-ter-
minally truncated in lung-cancer cells [73,74]. The exact
mechanism of inactivating its function as a tumor suppressor
is unknown, but is most likely to be independent of the myr-
istoylation status as the truncated protein form would still
contain the predicted myristoylation motif. It is possible that
CpG methylation downstream of the unmethylated 5' pro-
moter region [73] could account for inactivation, as the CpG
island appears to extend over the whole coding region (as
tested with methods described in [75]). For example, in the
case of the HIC1 tumor suppressor, CpG methylation was
found to occur predominantly in introns and exons instead of
the 5' promoter region. This methylation appears to be char-
acteristic for cancer types and stages [76].
Myristoylation and potassium channels
Myristoylation has been predicted for specific modulatory
proteins interacting with voltage-gated potassium channels
[77]. In this work, we demonstrate in vitro myristoylation of
the human representative of the KChIP1 subgroup of Kv4
channel-interacting proteins (Table 6 and Additional data file
1). The myristoylation motif is conserved in mouse, rat and
human and, in support, there exists homology to hippocalcin,
frequenin and neuronal calcium sensor proteins [77], whose
myristoylation has already been shown experimentally to be
of functional importance [78]. However, amino-terminal
truncation experiments with KChIP1 suggest that, in the
investigated system, the modulatory activity is sufficiently
represented by the more conserved central domain contain-
ing EF-hand Ca2+-binding motifs [79]. On the other hand, the
role of a myristoyl lipid anchor for KChIP1 could also lie in
subcellular targeting specificity. Voltage-gated potassium
channel isoforms (for example, Kv2.1 and Kv1.5) can localize
to distinct lipid-raft populations [80]. In the context of the
similar targeting specificity of acyl chains [81], it is interesting
that isoforms KChIP2 and KChIP3 that lack the predicted
myristoylation motif are palmitoylated, and their lipid
modification controls the plasma-membrane localization of
the associated channels [82].
Furthermore, several mammalian and avian homologs of the
strong inward rectifying potassium channel Kir2.1 are pre-
dicted to be myristoylated. The fact that the motif is
evolutionarily retained over 11 organisms would rather sup-
port the functional importance of such conservation. The in
vitro results show that the amino terminus of human Kir2.1
can productively interact with NMT (Table 6 and Additional
data file 1). None of the other Kirs is predicted to be
5 PF00891 O-methyltransferase
5 PF00046 Homeobox domain
5 PF05003 Protein of unknown function (DUF668)
5 PF00010 Helix-loop-helix DNA-binding domain
5 PF00170 bZIP transcription factor
5 PF00018 SH3 domain
5 PF00255 Glutathione peroxidase
5 PF00017 SH2 domain
5 PF00089 Trypsin
5 PF00153 Mitochondrial carrier protein
Table 4 (Continued)
Domain composition of the set of new predictionshttp://genomebiology.com/2004/5/3/R21 Genome Biology 2004,     Volume 5, Issue 3, Article R21       Maurer-Stroh et al. R21.11
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myristoylated, and a lipid anchor unique to Kir2.1 could be
responsible for differing subcellular and submembrane local-
izations of isoforms, similar to those observed among other
potassium channels [80,83].
Consequently, it is not surprising that artificial introduction
of a myristoylation motif into the isolated cytosolic carboxy
terminus of another Kir (Kir3.1) is sufficient to co-localize the
fragment with intact channels [84]. After synthesis in the ER,
carboxy-terminal signals direct the export of Kir2.1 to the
Golgi complex [85,86]. Stockklausner et al. [87] showed that
a cluster of positive charges in the amino terminus that are
conserved with Kir1.2/4.1 can be held responsible for post-
Golgi trafficking of Kir2.1 to the plasma membrane. There,
Kir2.1 is localized to lipid rafts [87]. It was hypothesized that
interaction with phosphoinositides (PIP2) could be necessary
for lipid-raft association but Stockklausner et al. [87] found
that mutation of the corresponding residues had no effect on
lipid-raft targeting. Other work suggests the involvement of
PIP2 interaction in regulating gating processes [88].
The functional role of the predicted myristoyl anchor for
these channel proteins with respect to submembrane
localization (lipid rafts), conformational flexibility of the
amino terminus or protein-protein interactions remains to be
investigated.
Myristoylation and targeting to lipid rafts
Many pieces of evidence suggest that not only the many dif-
ferent membranes in the cell, but also the microcompart-
ments therein, can be distinguished by their lipid and protein
compositions [89,90]. Proteomic analyses of detergent-
Table 5
Examples of proteins predicted to be myristoylated
Protein(s) Total number in 
MYRbase
MI in MYRbase (number in cluster) Taxonomic range
*Disease-resistance proteins 32 25300600 (27) NB-ARC+LRR, 25453543 (5) 
TIR+NB-ARC+LRR
Plants
†S/T protein phosphatase 2C 
gamma (1G)
30 2130393 (6)(ptc3), 26450759 (6), 4505999 
(5)(1G), 25411959 (4), 22326510 (3), 6728987 
(3), 6319415 (3)(ptc2/3), 23172576 
(3)Dm,23615237 (2)Pf, 22326564 (2), 7488279 
(2), 15239565 (1), 23483487 (1)(1Gpf), 
24417194 (1), 25341907 (1), 21626866 
(1)(1Gdm), 6319601 (1)(ptc4)
Mammals, insects, fungi, plants, 
apicomplexa
S/T-kinases (Crk1(cyclin-dependent 
kinase cdc2-related)-related)
29 22327464 (11), 27817936 (10), 14532736 (4), 
25402555 (3), 20805217 (1)
Plants
cGMP-specific 3',5'-cyclic 
phosphodiesterase 8A, 8B, 9A
23 6166014 (10) 9A, 27479159 (9) 8AB, 
21626649 (2) Dm, 2706887 (2)
Mammals, insects
*Thioredoxin 20 15231958 (11), 1388078 (4), 28209505 (2), 
28372832 (2), 28372834 (1)
Plants
Putative RING zinc finger proteins 
(ubiquitin ligases?)
17 20279471 (10), 27500282 (4) Hs Mm, 7292914 
(1) Dm, 3874246 (1) Ce, 23488532 (1) Pf
Plants, mammals, insects, 
apicomplexa
Interferon-inducible GTPase; 47 
kDa GTPase IIGP
16 25029534 (16) Mammals
Mitochondrial import receptor 
subunit TOM40
16 12230369 (15), 6539563 (1) Mammals, amphibians, insects, 
plants
‡Germ cell less GCL 15 21314704 (13), 7304006 (1), 6425507 (1) Mammals, fish, insects, worms
Inward rectifier potassium channel 
Kir2.1
13 26336911 (13) Mammals
Sphingolipid delta 4 desaturase 
DES1/DES2
12 27717299 (12) Mammals, insects, worms
ARF GTPase-activating protein (PH, 
ArfGAP, ankyrin domains)
12 22051029 (12) Mammals
Naked cuticle 1,2 homolog 12 22028145 (11), 27729789 (1) Mammals
Protein-L-isoaspartate 
carboxylmethyltransferase
12 27882417 (10), 27713894 (1), 3133008 (1) Mammals, amphibians, worms
Cyclin-box carrying protein 1 11 1078903 (11) Mammals, insects, worms
Amino-terminal peptides of single representatives shown to be myristoylated in *[24] and †[152]. ‡Amino-terminal glycine to alanine mutation 
prevents nuclear envelope localization [153].R21.12 Genome Biology 2004,     Volume 5, Issue 3, Article R21       Maurer-Stroh et al. http://genomebiology.com/2004/5/3/R21
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resistant lipid-raft fractions from different cells [91-94]
unveil partly overlapping but also cell-type specific popula-
tions of proteins. This includes several known myristoylated
proteins that are involved in various signaling pathways (for
example, Gα [95], Src-family tyrosine kinases [96], NAP-22
[97], endothelial nitric oxide synthase [98], rapsyn [99],
annexin XIII [100], MARCKS [101], CAP23 [102]) and Nef
[103] or participate in viral budding (for example, HIV Gag
[104]).
In addition, we predict myristoylation for two more proteins
of unknown function that co-localized with detergent-resist-
ant membrane fractions. Each appears in a separate pro-
teomic analysis of lipid rafts in Jurkat T-cells [91,94]. The
first (161 amino acids, MI 8923579) protein has a conserved
myristoylation site plus potentially palmitoylated cysteines in
human, rat and mouse homologs. Interestingly, the second
protein (227 amino acid, MI 12834233), which has a pre-
dicted central coiled coil region, was not only detected in
detergent-resistant fractions of T cells in a dynamic, receptor-
activation-dependent manner [94], but also in a chaotrope-
resistant fraction derived from nuclei of neuroblastoma N2a
cells that contains clusters of proteins localizing to the outer
nuclear membrane [105]. It will be interesting to establish
possible dynamic trafficking between distinct subcellular
compartments of this protein (with highly conserved
orthologs in human, mouse and frog, and more diverged in
zebrafish and fly).
Existing proteomic analyses focus on the most abundant pro-
tein representatives within membrane fractions and can also
only identify a temporally limited subset of dynamically tar-
geted proteins. Therefore, it would not be surprising to find
several more myristoylated proteins to participate in highly
specific signaling events by reversible trafficking to and from
membrane microdomains.
Targeting experiments suggest differences in submembrane
localization that depend on the anchor type. For example,
membrane partition clustering of non-dimerizing green fluo-
rescent protein variants fused to peptides containing double
acylation (for example, myristoyl+palmitoyl) or prenylation
(for example, farnesyl, geranylgeranyl) consensus signals was
shown to differentially depend on lipid raft disruption by cho-
lesterol depletion [81]. However, targeting experiments with
a few artificial constructs varying only in lipid anchor type
cannot take into account the complexity of the interplay
between different MAFs that coexist in real proteins. Hence,
it is difficult to generally attribute targeting specificity purely
to occurrences of particular lipid anchors. Nevertheless, a
myristoyl anchor followed by a palmitoyl anchor seems to be
a strong indication for targeting to the plasma membrane and
also eventually to lipid rafts.
Conclusions
We have evaluated the evolutionary conservation of predicted
glycine myristoylation within sequences of the eukaryotic sec-
tion of GenBank. We find that a small number of very large
families of myristoylated proteins seems to be opposed to a
large number of very small protein families (Figure 1). Our
approach allows the summarizing of the currently available
knowledge of experimentally verified (Table 2) as well as
newly predicted myristoylated eukaryotic proteins (examples
in Table 5, throughout the text and in MYRbase).
We estimate that a substantial fraction of new predictions is
associated with proteins whose function has not been known
in the context of myristoylation (Tables 1, 4, 5) so far. By
demonstrating  in vitro myristoylation of amino termini
derived from several interesting functionally diverse proteins
(Table 6 and Additional data file 1), we strengthen the predic-
tion results for this lipid modification. Nevertheless, we also
want to emphasize that the actual in vivo modification of
respective proteins remains to be established.
The myristoylation motif typically acts together with several
other MAFs but can also be fully replaced by them within
Table 6
Diverse amino termini of selected sequences shown to undergo in vitro myristoylation
Human protein MYRbase identifier Myristoylation motif
Immunoglobulin µ-heavy chain 27650590 GGTFSSYAISWVRQAPG
Immunoglobulin λ-light chain 4761381 GQTASITCSGDKLGDKY
47 kDa GTPase IIGP 23682869 GQLFSSRRSEDQDLSSS
Ubiquitin hydrolase Ubq-M 5454156 GKKRTKGKTVPIDDSSE
Lung cancer candidate FUS1 6005760 GASGSKARGLWPFASAA
Potassium channel interacting protein KChIP1 7657247 GAVMGTFSSLQTKQRRP
Potassium channel Kir2.1 2282068 GSVRTNRYSIVSSEEDG
Residues indicated in bold type are positively charged; The C denoted in italic type indicates a palmitoylatable cysteine.http://genomebiology.com/2004/5/3/R21 Genome Biology 2004,     Volume 5, Issue 3, Article R21       Maurer-Stroh et al. R21.13
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protein families during evolution. The concerted effect of
these MAFs defines subcellular localization and targeting
specificity. We classify five coMAFs that most commonly co-
occur with myristoyl lipid modifications (Table 3, Figure 2).
The results of this work are summarized and accessible
through the web-based MYRbase [18] that aims to stimulate
further experiments. A considerable amount of work will be
necessary in the future to fully cover and understand the func-
tional spectrum of the myristoylated proteins.
Materials and methods
In vitro myristoylation assay
The amino-terminal eight amino acids of selected predictions
(Table 6) were synthesized with two minor modifications. To
avoid racemization of the carboxy-terminal cysteine, one
serine residue was added to t h e  t e r m i n u s  o f  M I  4 7 6 1 3 8 1 .
Threonine and valine were added to the octapeptide of MI
5454156, as the dominance of positive charges was expected
to result in difficulties in purification and handling. Peptides
were purchased from Sigma Genosys (Japan). NMT was pre-
pared as described previously [106] and the cDNA of yeast
NMT was a gift from J. Gordon. Peptides were myristoylated
in vitro essentially as described in [107] and analyzed by mass
spectrometry. MALDI-TOF mass spectrometry was carried
out on a Voyager DE Pro (PE Biosystems) and the matrix was
10 mg/ml alpha-cyano-4-hydroxycinnamic acid (Sigma) in
0.1% TFA-50% acetonitrile solution. The spectra were dis-
played and analyzed using the GRAMS-MS software and the
spectra were calibrated using calibration mixture 1 or 2 (PE
Biosystems). The spectra are available in portable document
format (PDF) from the MYRbase homepage [18]. As positive
controls, peptides of proteins known to be myristoylated in
vivo have been analyzed, as well as corresponding peptides
without modification by NMT as negative controls. Differ-
ences between theoretical and experimental masses for pep-
tides ending in serine are most likely due to carboxy-terminal
sodium salt formation. MYRbase identifiers can be found in
the upper left corner of each page.
Additional data files
The mass spectra of the investigated peptides are available
(Additional data file 1).
Additional data file 1 The mass spectra of the investigated peptides The mass spectra of the investigated peptides Click here for additional data file
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